The Transcriptional Activation Domain of VP16 Is Required for Efficient Infection and Establishment of Latency by HSV-1 in the Murine Peripheral and Central Nervous Systems
- 1 June 1999
- Vol. 259 (1) , 20-33
- https://doi.org/10.1006/viro.1999.9756
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma.Proceedings of the National Academy of Sciences, 1995
- Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivationMicrobial Pathogenesis, 1993
- ‘Touchdown’ PCR to circumvent spurious priming during gene amplificationNucleic Acids Research, 1991
- A review of the molecular mechanism of HSV-1 latencyCurrent Eye Research, 1991
- Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate-early gene expressionJournal of Virology, 1989
- Establishment and Characterization of the Human Medulloblastoma Cell Line and Transplantable Xenograft D283 MedJournal of Neuropathology and Experimental Neurology, 1985
- Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcriptionJournal of Molecular Biology, 1984
- The immunocytochemical detection of Herpes simplex virus in cervical smears—a valuable technique for routine useThe Journal of Pathology, 1984
- A severe combined immunodeficiency mutation in the mouseNature, 1983
- Genetic Studies with Herpes Simplex Virus Type 1. The Isolation of Temperature-sensitive Mutants, their Arrangement into Complementation Groups and Recombination Analysis Leading to a Linkage MapJournal of General Virology, 1973